JAVED FAZAL: Open Payments
NPI 1942243704 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,243 in 40 payments from 14 companies in 2025. Trend: 2023 $1,583 · 2024 $1,179 · 2025 $1,243
Food & beverage: $1,035Education: $208
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $316 |
| AstraZeneca Pharmaceuticals LP | 5 | $210 |
| ABBVIE INC. | 8 | $192 |
| Novo Nordisk Inc | 7 | $169 |
| PFIZER INC. | 5 | $107 |
| Lilly USA, LLC | 4 | $80 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $34 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $21 |
Products named: TREMFYA, BREZTRI, Ozempic, QULIPTA, NURTEC ODT, MOUNJARO, VRAYLAR, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
